How it works
Help & support
Subscribe to your search as RSS
A new European Consortium to improve therapeutic guidance for patients with metastatic breast cancer
Dec 04, 2013 09:39 EST
The CareMore* Consortium is a collaborative effort to advance diagnostic systems for th...
Olink Bioscience introduces a 92 protein biomarker panel for cardiovascular disease
Oct 29, 2013 08:57 EDT
Uppsala, Sweden, October 29, 2013 – Olink Bioscience today launches Proseek Multiplex C...
Fluidigm and Olink Bioscience Bring a New Level of Protein Biomarker Discovery to the Life Science Research Market - 96 Samples Across 92 Proteins in One Microfluidic Run
Jul 31, 2013 09:12 EDT
Fluidigm and Olink Bioscience have teamed up to enable interrogation of 96 samples acro...
A new European Consortium to boost our understanding of Inflammatory Bowel Diseases
May 17, 2013 08:21 EDT
The Inflammatory Bowel Disease CHARACTERization by a multi-modal integrated biomarker s...
Olink Bioscience Introduces Scalable Protein Biomarker Assays with Proseek Multiplex
Mar 12, 2013 08:57 EDT
Olink launches Proseek Multiplex – a new generation of multiplexed protein biomarker im...
Olink Bioscience appoints Sigma-Aldrich as distributor of Duolink
Feb 12, 2013 08:44 EST
Uppsala, Sweden, February 12, 2013 – Olink Bioscience today announced the appointment o...
Carbon monoxide why experts are a must.
Feb 14, 2012 04:06 EST
In the event that you have suffered damage after a carbon monoxide exposure if you don'...
Olink AB and Bethyl sign distribution agreement for the US market
Nov 21, 2011 09:00 EST
Olink Bioscience, a Sweden based biotechnology company focused on innovative protein de...
Olink Appoints New CEO and Expands Board of Directors
Sep 14, 2011 09:32 EDT
UPPSALA, Sweden, 14 September 2011 – Dr. Simon Fredriksson, Executive Vice President an...
nxt2b becomes a major shareholder in Olink AB
Aug 29, 2011 08:20 EDT
nxt2b (Nexttobe AB) an investment company owned by Bengt Ågerup, has today signed an a...